From next week, Russia begins curing patients with Coddy-19 through the AviFavitri drug

The move says it will lower its load on the health system and speed up the return to normal economic life.

Russian hospitals will begin to provide antiviral medicine, which is registered by the name AviFaviviri, for patients from June 11th. He said the company behind this drug will produce enough to treat 60 thousand people per month, Reuters writes, translate Periscopi.

So far there's no vaccine for Coddy-19, the disease caused by the new coronary, and tests on people from some existing antiviral drugs have yet to demonstrate efficiency in fighting the virus.

The new anti-virus drug from Gileaad called Remdesivirir has shown promising signs in several tests against Avid-19, and is being given to patients in several different sells.

Avifaviviviviviviviviri, known as Favipiraver, was first developed in the late 1990s by a Japanese company that was later purchased by Fujifilm when this company had started working in the healthcare industry. /Periscope